Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Share-based Compensation (2016 - 2025)

Dare Bioscience's Share-based Compensation history spans 11 years, with the latest figure at $357160.0 for Q4 2025.

  • For Q4 2025, Share-based Compensation fell 27.0% year-over-year to $357160.0; the TTM value through Dec 2025 reached $1.5 million, down 32.07%, while the annual FY2025 figure was $1.5 million, 32.07% down from the prior year.
  • Share-based Compensation reached $357160.0 in Q4 2025 per DARE's latest filing, down from $403027.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $650186.0 in Q2 2023 to a low of $357160.0 in Q4 2025.
  • Average Share-based Compensation over 5 years is $499435.2, with a median of $527855.5 recorded in 2022.
  • Peak YoY movement for Share-based Compensation: skyrocketed 127.5% in 2021, then plummeted 39.88% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $388806.0 in 2021, then surged by 36.86% to $532133.0 in 2022, then grew by 16.47% to $619791.0 in 2023, then dropped by 21.06% to $489260.0 in 2024, then decreased by 27.0% to $357160.0 in 2025.
  • Per Business Quant, the three most recent readings for DARE's Share-based Compensation are $357160.0 (Q4 2025), $403027.0 (Q3 2025), and $359018.0 (Q2 2025).